Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02971930 · ClinicalTrials.gov registry record
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 30
- Enrollment target
NCT02971930 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 30 participants.
The verdict
NCT02971930 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is to generate qualitative data to evaluate the impact of frequency of FVIII infusions on patients' satisfaction with treatment and their quality of life.
Interventions
- BIOLOGICAL BAY94-9027
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2017-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02971930
The ClinicalTrials.gov registry entry for NCT02971930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BAY94-9027 is the first listed.
NCT02971930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02971930 about?
NCT02971930 is a clinical study titled "Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A". This study is to generate qualitative data to evaluate the impact of frequency of FVIII infusions on patients' satisfaction with treatment and their quality of life.
What is the current status of trial NCT02971930?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-06-20. Estimated completion is 2017-12-15.
What interventions are being tested in trial NCT02971930?
The interventions under investigation include: BAY94-9027 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02971930?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.